NNE provided a pre-study, supporting management decision on feasibility for establishing in-house API development and production facility, including an initial master plan.
The customer's key driver was CAPEX/OPEX and secondly, to attract investors for funding of the project. NNE's pre-study aimed to support the customer's internal management decision on in-house development and manufacturing feasibility as well as to to help the customer attract investors for funding, by showcasing the assets of the project. We thus developed a prospect to apply for funding, visuals to support key points and an initial cost estimate and schedule.
Active pharmaceuticals ingredients and monoclonal antibodies
Workshop with customer
Total of 4 weeks